This study is an observational cohort study to document prevalence and severity of neurological symptoms among patients younger than 18 years old admitted to the hospital with confirmed or presumed novel coronavirus (COVID 19). This study contains common data elements that all sites are requested to obtain (Tier 1 data). Tier 1 data are generally obtainable from electronic medical records and similar sources, under an IRB protocol allowing waiver of consent. Interested sites may also collect Tier 2 data such as standardized outcome measures at a later time point (~ 1 month after hospital discharge). A second IRB for tier 2 data would require informed consent, as would the process of data sharing outside the institution. We will provide IRB templates for both Tier 1 and 2 as well as a Case Report Form upon registration of your unique site.
Please note: All registered sites will receive access to study protocols and case report forms (CRF). It is the responsibility of each study site and principal investigator to submit these documents to their institutional officials to obtain the required ethical and organizational approvals before collecting any data.